Benjamin Louis England
Is this your profile?
Claim it for free to update your information and connect with clients.
Contact
Professional
About
Benjamin Louis England is a seasoned attorney based in Glen Burnie, MD, specializing in investigations and personal injury law. With over 17 years of experience at the U.S. Food and Drug Administration (FDA), he brings a wealth of knowledge and expertise to his practice. As the Founder and CEO of Benjamin L. England & Associates, Mr. England assists clients in navigating the complexities of FDA regulations and compliance, ensuring that their products meet the stringent requirements set by federal agencies including the USDA, FTC, and EPA. His extensive background includes roles as Regulatory Counsel to the Associate Commissioner for Regulatory Affairs, FDA Consumer Safety Officer, and Senior Special Agent with the Office of Criminal Investigations. Throughout his distinguished career, Mr. England has received numerous awards from the Department of Health and Human Services and the FDA for his exemplary service. Mr. England’s practice focuses on challenging FDA administrative actions, managing import/export compliance issues, and ensuring product labeling adheres to legal standards for foods, drugs, medical devices, dietary supplements, and cosmetics. He also specializes in assisting companies with pre-market notifications (510(k)s) and export certifications. He holds a Juris Doctor degree from the University of Miami School of Law (1999) and a Bachelor of Arts from the University of Maryland Baltimore County (1990). His foundational education was completed at Grace College and Seminary in 1984. Committed to excellence, Mr. England continues to advocate for his clients and uphold the highest standards in legal representation.
About Antitrust Trade Law
Antitrust attorneys handle matters involving competition law, market practices, and trade regulations. They help businesses comply with antitrust laws and defend against claims. Common matters include price fixing, monopoly claims, merger review, trade practices.